During a three-year follow-up, 8.9% of those taking semaglutide were diagnosed with NAION in comparison to 1.8% on other diabetes drugs
For example, commenters indicated that it was not clear from the proposed instructions how hospitals should (1) crosswalk the MAO's payment methodology to an MS-DRG for payers that do not use the MS-DRG as a basis of payment and (2) calculate the cases for the weighted median
Kane J, Honigfeld G, Singer J, Meltzer H
The frequency of IV therapy sessions can be tailored to the patients health goals, ensuring sustained benefits over time
Tirzepatide SURMOUNT-1 (NEJM 2022)
Based on preclinical evidence that GLP-1RAs reduce voluntary nicotine self-administration, 55 recent studies have evaluated GLP-1RAs for smoking cessation and prevention of postcessation weight gain